5 Easy Facts About cGMP Described
No. 21 CFR 211.113(a) demands acceptable published strategies to be established and followed throughout manufacturing to circumvent objectionable microorganisms in drug products and solutions not needed to be sterile. In addition, the next paragraph of USP Normal Chapter Antimicrobial Performance Screening reads: Antimicrobial preservative